|
|
pigmentation
|
GO:0043473 |
71 |
0.889
|
Mouse |
|
|
embryonic heart tube left right pattern formation
|
GO:0060971 |
5 |
0.849
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.812
|
|
|
|
determination of digestive tract left right asymmetry
|
GO:0071907 |
1 |
0.672
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.591
|
|
|
|
embryonic heart tube anterior posterior pattern specification
|
GO:0035054 |
3 |
0.579
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.544
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.518
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.506
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.493
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.452
|
|
|
|
cardioblast migration to the midline involved in heart field formation
|
GO:0060975 |
1 |
0.434
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.430
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.421
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.418
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.397
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.376
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.376
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.365
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.359
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.348
|
|
|
|
left right pattern formation
|
GO:0060972 |
23 |
0.340
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.339
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.338
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.331
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.322
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.316
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.293
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.290
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.285
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.270
|
|
|
|
vascular smooth muscle cell differentiation
|
GO:0035886 |
11 |
0.259
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.259
|
|
|
|
negative regulation of glial cell derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation
|
GO:2000734 |
1 |
0.253
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.250
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.247
|
Mouse |
|
|
heart field specification
|
GO:0003128 |
6 |
0.246
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.242
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.234
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.232
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.228
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.212
|
|
|
|
secondary heart field specification
|
GO:0003139 |
6 |
0.211
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.208
|
|
|
|
positive regulation of axon guidance
|
GO:1902669 |
5 |
0.207
|
|
|
|
sperm ejaculation
|
GO:0042713 |
1 |
0.205
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.204
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.197
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.193
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.187
|
|
|
|
cardioblast migration
|
GO:0003260 |
1 |
0.183
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.183
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.182
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.182
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.180
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.172
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.164
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.161
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.158
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.158
|
|
|
|
cardiac vascular smooth muscle cell development
|
GO:0060948 |
3 |
0.155
|
|
|
|
glial cell derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation
|
GO:2000701 |
1 |
0.154
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.153
|
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.151
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.149
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.148
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.148
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.146
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.143
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.142
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.142
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.141
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.141
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.140
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.139
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.137
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.137
|
|
|
|
trachea formation
|
GO:0060440 |
3 |
0.135
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.132
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.132
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.132
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.130
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.128
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.128
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.125
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.124
|
|
|
|
detection of chemical stimulus involved in sensory perception of taste
|
GO:0050912 |
3 |
0.124
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.121
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.120
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.120
|
|
|
|
cell migration to the midline involved in heart development
|
GO:0003318 |
1 |
0.119
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.119
|
|
|
|
foregut morphogenesis
|
GO:0007440 |
12 |
0.119
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.118
|
|
|
|
venous blood vessel development
|
GO:0060841 |
13 |
0.117
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.117
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.116
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.116
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.115
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.114
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.114
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.113
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.113
|
|
|
|
venous blood vessel morphogenesis
|
GO:0048845 |
7 |
0.111
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.110
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.109
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.109
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.109
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.108
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.108
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.107
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.106
|
|
|
|
positive regulation of creb transcription factor activity
|
GO:0032793 |
4 |
0.104
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.104
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.104
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.103
|
|
|
|
lateral mesodermal cell differentiation
|
GO:0048371 |
3 |
0.103
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.102
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.101
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.101
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.100
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.100
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.100
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.099
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.098
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.098
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.097
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.097
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.096
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.096
|
|
|
|
endothelial tube morphogenesis
|
GO:0061154 |
2 |
0.095
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.095
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.094
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.094
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.094
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.093
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.093
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.092
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.092
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.092
|
|
|
|
lung saccule development
|
GO:0060430 |
7 |
0.092
|
|
|
|
transcriptional activation by promoter enhancer looping
|
GO:0071733 |
2 |
0.091
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.091
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.091
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.090
|
|
|
|
ductus arteriosus closure
|
GO:0097070 |
3 |
0.088
|
|
|
|
protein localization to endosome
|
GO:0036010 |
2 |
0.088
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.088
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.087
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.087
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.086
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.086
|
Mouse |
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.086
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.086
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
25 |
0.086
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.086
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.086
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.085
|
|
|
|
negative regulation of macrophage differentiation
|
GO:0045650 |
4 |
0.085
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.084
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.083
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.083
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.082
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.082
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.082
|
Mouse |
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.081
|
|
|
|
p38mapk cascade
|
GO:0038066 |
4 |
0.081
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.080
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.080
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.080
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.079
|
|
|
|
activin receptor signaling pathway
|
GO:0032924 |
18 |
0.079
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.079
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.079
|
|
|
|
regulation of transcription involved in primary germ layer cell fate commitment
|
GO:0060796 |
2 |
0.078
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.078
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.078
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.078
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.078
|
Mouse |
|
|
gastrulation with mouth forming second
|
GO:0001702 |
29 |
0.078
|
|
|
|
lung lobe formation
|
GO:0060464 |
1 |
0.077
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.077
|
|
|
|
regulation of ureteric bud formation
|
GO:0072106 |
3 |
0.077
|
|
|
|
positive regulation of ureteric bud formation
|
GO:0072107 |
3 |
0.077
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.077
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.076
|
|
|
|
hypothalamus cell migration
|
GO:0021855 |
5 |
0.076
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.076
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.075
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.074
|
|
|
|
otolith morphogenesis
|
GO:0032474 |
3 |
0.074
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.073
|
|
|
|
regulation of definitive erythrocyte differentiation
|
GO:0010724 |
3 |
0.073
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
18 |
0.073
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.073
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.073
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.072
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.072
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.072
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.071
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.071
|
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.071
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.070
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.070
|
|
|
|
germ line stem cell maintenance
|
GO:0030718 |
6 |
0.070
|
|
|
|
atrioventricular node development
|
GO:0003162 |
3 |
0.070
|
|
|
|
endothelial cell fate commitment
|
GO:0060839 |
2 |
0.070
|
|
|
|
floor plate morphogenesis
|
GO:0033505 |
3 |
0.069
|
|
|
|
pro t cell differentiation
|
GO:0002572 |
3 |
0.069
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.069
|
Mouse |
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.068
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.068
|
|
|
|
ammonia homeostasis
|
GO:0097272 |
1 |
0.068
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.068
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.067
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.067
|
|
|
|
determination of left right asymmetry in nervous system
|
GO:0035545 |
1 |
0.067
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.067
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.066
|
Human |
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.066
|
|
|
|
somite specification
|
GO:0001757 |
4 |
0.065
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.065
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.065
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.064
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.064
|
|
|
|
nephrogenic mesenchyme morphogenesis
|
GO:0072134 |
2 |
0.064
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.064
|
|
|
|
regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation
|
GO:2000702 |
1 |
0.064
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.063
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.063
|
|
|
|
regulation of cell proliferation involved in mesonephros development
|
GO:2000606 |
1 |
0.063
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.063
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.062
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.062
|
|
|
|
regulation of forebrain neuron differentiation
|
GO:2000977 |
2 |
0.062
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.062
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.062
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.061
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.061
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.061
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.061
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.061
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.061
|
|
|
|
arterial endothelial cell differentiation
|
GO:0060842 |
5 |
0.061
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.060
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.060
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.060
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.059
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.059
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.059
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.058
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.058
|
|
|
|
epithelial to mesenchymal transition involved in endocardial cushion formation
|
GO:0003198 |
10 |
0.058
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.058
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.058
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.058
|
|
|
|
cell proliferation involved in mesonephros development
|
GO:0061209 |
4 |
0.058
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.058
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.058
|
|
|
|
fasciculation of sensory neuron axon
|
GO:0097155 |
3 |
0.057
|
|
|
|
lateral mesoderm morphogenesis
|
GO:0048369 |
3 |
0.057
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
2 |
0.057
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.057
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.057
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.056
|
|
|
|
mating
|
GO:0007618 |
27 |
0.056
|
|
|
|
urea homeostasis
|
GO:0097274 |
2 |
0.056
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.056
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.056
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.056
|
|
|
|
fused antrum stage
|
GO:0048165 |
1 |
0.056
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.056
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.056
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.055
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.055
|
|
|
|
canonical wnt signaling pathway involved in metanephric kidney development
|
GO:0061290 |
2 |
0.055
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.054
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
13 |
0.054
|
|
|
|
coronary vasculature development
|
GO:0060976 |
12 |
0.054
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
11 |
0.054
|
|
|
|
pulmonary artery morphogenesis
|
GO:0061156 |
3 |
0.054
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.053
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.053
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.053
|
|
|
|
gene looping
|
GO:0090202 |
2 |
0.053
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.053
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.053
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.052
|
|
|
|
monocyte differentiation
|
GO:0030224 |
9 |
0.052
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.052
|
|
|
|
positive regulation of erythrocyte differentiation
|
GO:0045648 |
11 |
0.052
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.052
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.052
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.052
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.052
|
|
|
|
regulation of endothelial cell differentiation
|
GO:0045601 |
10 |
0.052
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.052
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.051
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.051
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.051
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.051
|
|
|
|
blood vessel endothelial cell differentiation
|
GO:0060837 |
6 |
0.051
|
|
|
|
endocardial cushion cell differentiation
|
GO:0061443 |
1 |
0.051
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.051
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.051
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.050
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.050
|
|
|
|
positive regulation of b cell tolerance induction
|
GO:0002663 |
2 |
0.050
|
|
|
|
neuropilin signaling pathway
|
GO:0038189 |
2 |
0.050
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.050
|
|
|
|
negative regulation of endothelial cell differentiation
|
GO:0045602 |
2 |
0.050
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.049
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.049
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.049
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.049
|
|
|
|
negative regulation of mechanoreceptor differentiation
|
GO:0045632 |
3 |
0.049
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
2 |
0.049
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.049
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.049
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.049
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.048
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.048
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.048
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.048
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.048
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.048
|
|
|
|
growth plate cartilage chondrocyte development
|
GO:0003431 |
3 |
0.048
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.048
|
|
|
|
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis
|
GO:0060598 |
2 |
0.048
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.048
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.048
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.047
|
|
|
|
positive regulation of cardiac muscle cell proliferation
|
GO:0060045 |
15 |
0.047
|
|
|
|
growth involved in heart morphogenesis
|
GO:0003241 |
4 |
0.047
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.047
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.047
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.047
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.046
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.046
|
|
|
|
positive regulation of tolerance induction to self antigen
|
GO:0002651 |
1 |
0.046
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.046
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.045
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.045
|
|
|
|
commitment of neuronal cell to specific neuron type in forebrain
|
GO:0021902 |
7 |
0.045
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.045
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
8 |
0.045
|
|
|
|
atrioventricular valve formation
|
GO:0003190 |
5 |
0.045
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.045
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.045
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.045
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.045
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.045
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.045
|
|
|
|
regulation of astrocyte differentiation
|
GO:0048710 |
20 |
0.045
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.045
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.045
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
13 |
0.045
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.045
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.044
|
|
|
|
glial cell fate determination
|
GO:0007403 |
3 |
0.044
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.044
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.044
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.044
|
|
|
|
positive regulation of biomineral tissue development
|
GO:0070169 |
12 |
0.044
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.044
|
|
|
|
prechordal plate formation
|
GO:0021501 |
1 |
0.044
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.044
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.044
|
|
|
|
regulation of inositol 1 4 5 trisphosphate sensitive calcium release channel activity
|
GO:0031585 |
2 |
0.044
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.044
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.044
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.044
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.044
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.043
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.043
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.043
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.043
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.043
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.043
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.043
|
|
|
|
lymph vessel morphogenesis
|
GO:0036303 |
11 |
0.043
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.043
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.042
|
|
|
|
cellular divalent inorganic anion homeostasis
|
GO:0072501 |
3 |
0.042
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.042
|
|
|
|
regulation of smad protein import into nucleus
|
GO:0060390 |
3 |
0.042
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
13 |
0.042
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.042
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.042
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.042
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.042
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.042
|
|
|
|
regulation of b cell tolerance induction
|
GO:0002661 |
2 |
0.042
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.041
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.041
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.041
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.041
|
|
|
|
embryonic neurocranium morphogenesis
|
GO:0048702 |
3 |
0.041
|
|
|
|
heart formation
|
GO:0060914 |
16 |
0.041
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.040
|
|
|
|
negative regulation of cell proliferation involved in mesonephros development
|
GO:2000607 |
1 |
0.040
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.040
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.040
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.040
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.040
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.040
|
|
|
|
primitive erythrocyte differentiation
|
GO:0060319 |
3 |
0.040
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.040
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.040
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.040
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.040
|
|
|
|
negative regulation of transcription by competitive promoter binding
|
GO:0010944 |
1 |
0.040
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.040
|
|
|
|
positive regulation of transcription regulatory region dna binding
|
GO:2000679 |
1 |
0.040
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.039
|
|
|
|
metanephric ascending thin limb development
|
GO:0072218 |
2 |
0.039
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.039
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.039
|
Mouse |
|
|
membrane organization
|
GO:0061024 |
245 |
0.039
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.039
|
|
|
|
cell migration involved in heart formation
|
GO:0060974 |
1 |
0.038
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.038
|
Mouse |
|
|
cation transport
|
GO:0006812 |
399 |
0.038
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.038
|
|
|
|
regulation of glial cell derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation
|
GO:2000733 |
1 |
0.038
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.038
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.038
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.038
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.038
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.038
|
|
|
|
growth plate cartilage chondrocyte growth
|
GO:0003430 |
2 |
0.038
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.037
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.037
|
|
|
|
tolerance induction
|
GO:0002507 |
14 |
0.037
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.037
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.037
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.037
|
|
|
|
mesoderm structural organization
|
GO:0048338 |
1 |
0.037
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.037
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.037
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
21 |
0.037
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.037
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.037
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.037
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.037
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.036
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.036
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.036
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.036
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.036
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.035
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.035
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.035
|
|
|
|
positive regulation of interleukin 13 production
|
GO:0032736 |
4 |
0.035
|
|
|
|
morphogenesis of an endothelium
|
GO:0003159 |
2 |
0.035
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.035
|
|
|
|
bronchus morphogenesis
|
GO:0060434 |
2 |
0.035
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.035
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.035
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.034
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.034
|
|
|
|
pulmonary valve development
|
GO:0003177 |
5 |
0.034
|
|
|
|
mesodermal cell fate specification
|
GO:0007501 |
11 |
0.034
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.034
|
Mouse |
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.034
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.034
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.034
|
|
|
|
response to cholesterol
|
GO:0070723 |
4 |
0.034
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.034
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.034
|
|
|
|
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation
|
GO:2000703 |
1 |
0.034
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.034
|
|
|
|
atrial septum morphogenesis
|
GO:0060413 |
11 |
0.034
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.034
|
|
|
|
axial mesodermal cell fate commitment
|
GO:0048322 |
1 |
0.034
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.034
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.034
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.034
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.033
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.033
|
|
|
|
sensory organ boundary specification
|
GO:0008052 |
1 |
0.033
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.033
|
|